Next Article in Journal
The BC Cancer Agency Compassionate Access Program: Outcome Analysis of Patients with Esophagogastric Cancer
Previous Article in Journal
Efficacy of Third-Line Therapy Using Bevacizumab in a Patient with Metastatic Colorectal Cancer
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 16
Issue 5
10.3747/co.v16i5.412
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Case Report

Resolution of Severe Oncogenic Hypophosphatemic Osteomalacia after Resection of a Deeply Located Soft-Tissue Tumour

by
A. R. M. Radaideh
1,
D. Jaradat
2,
M. M. Abu-Kalaf
3 and
M. K. Nusier
4,*
1
Departments of Medicine, Prince Basma Teaching Hospital, Ministry of Health, Irbid, Jordan
2
Departments of Radiology, Prince Basma Teaching Hospital, Ministry of Health, Irbid, Jordan
3
Department of Surgery, Jordan University, School of Medicine, Amman, Jordan
4
MedLabs Consultancy Group, Amman 11183, Jordan
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2009, 16(5), 87-90; https://0-doi-org.brum.beds.ac.uk/10.3747/co.v16i5.412
Submission received: 3 June 2009 / Revised: 8 July 2009 / Accepted: 5 August 2009 / Published: 1 September 2009

Abstract

Oncogenic osteomalacia is a rare metabolic bone disease characterized by phosphate leakage from the kidney and subsequent hypophosphatemia. It is caused by a phosphaturic factor produced by certain tumours. Removal of such tumours can completely cure the condition. Here, we report the case of a patient who was crippled with oncogenic osteomalacia. Extensive study revealed a tumour deeply located in the pelvis; removal of the tumour resulted in complete recovery. The tumour was identified as a mesenchymal tumour (mixed connective-tissue variant). The diagnostic evaluation, differential diagnosis, and treatment are discussed.
Keywords: oncogenic osteomalacia; mesenchymal tumour; mixed connective-tissue tumour; 1,25-dihydroxycholecalciferol; rickets; hypophosphatemia; fibroblast growth factor 23 oncogenic osteomalacia; mesenchymal tumour; mixed connective-tissue tumour; 1,25-dihydroxycholecalciferol; rickets; hypophosphatemia; fibroblast growth factor 23

Share and Cite

MDPI and ACS Style

Radaideh, A.R.M.; Jaradat, D.; Abu-Kalaf, M.M.; Nusier, M.K. Resolution of Severe Oncogenic Hypophosphatemic Osteomalacia after Resection of a Deeply Located Soft-Tissue Tumour. Curr. Oncol. 2009, 16, 87-90. https://0-doi-org.brum.beds.ac.uk/10.3747/co.v16i5.412

AMA Style

Radaideh ARM, Jaradat D, Abu-Kalaf MM, Nusier MK. Resolution of Severe Oncogenic Hypophosphatemic Osteomalacia after Resection of a Deeply Located Soft-Tissue Tumour. Current Oncology. 2009; 16(5):87-90. https://0-doi-org.brum.beds.ac.uk/10.3747/co.v16i5.412

Chicago/Turabian Style

Radaideh, A. R. M., D. Jaradat, M. M. Abu-Kalaf, and M. K. Nusier. 2009. "Resolution of Severe Oncogenic Hypophosphatemic Osteomalacia after Resection of a Deeply Located Soft-Tissue Tumour" Current Oncology 16, no. 5: 87-90. https://0-doi-org.brum.beds.ac.uk/10.3747/co.v16i5.412

Article Metrics

Back to TopTop